[go: up one dir, main page]

WO1993016180A3 - Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95) - Google Patents

Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95) Download PDF

Info

Publication number
WO1993016180A3
WO1993016180A3 PCT/EP1993/000382 EP9300382W WO9316180A3 WO 1993016180 A3 WO1993016180 A3 WO 1993016180A3 EP 9300382 W EP9300382 W EP 9300382W WO 9316180 A3 WO9316180 A3 WO 9316180A3
Authority
WO
WIPO (PCT)
Prior art keywords
antigen
fragment
tumor
molecular weight
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1993/000382
Other languages
French (fr)
Other versions
WO1993016180A1 (en
WO1993016180A2 (en
Inventor
Axel Ullrich
Irmingard Sures
Mohammad Azam
Stefano Iacobelli
Clara Natoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Publication of WO1993016180A1 publication Critical patent/WO1993016180A1/en
Publication of WO1993016180A2 publication Critical patent/WO1993016180A2/en
Publication of WO1993016180A3 publication Critical patent/WO1993016180A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention provides substantially purified tumor-associated 90K antigen, or fragment(s) thereof, especially from: the culture fluid of the human breast cancer cell line, CG-5; the serum of a breast cancer patient; or the ascitic fluid from an ovarian cancer patient. The native antigen, which has a molecular weight of about 95,000 daltons, is present as a high molecular weight complex. The purification and characterization of the antigen is provided as well as uses thereof. The nucleotide sequences which encode the 90K antigen, or fragment(s) thereof, vehicles containing the genetic sequence, hosts transformed therewith, and production of the antigen, or fragments thereof, by the transformed host are also provided.
PCT/EP1993/000382 1992-02-17 1993-02-17 Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95) Ceased WO1993016180A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM92A000100 1992-02-17
ITRM920100A IT1254309B (en) 1992-02-17 1992-02-17 GENETIC SEQUENCES FOR 90K ANTIGEN ASSOCIATED WITH CANCER.

Publications (3)

Publication Number Publication Date
WO1993016180A1 WO1993016180A1 (en) 1993-08-19
WO1993016180A2 WO1993016180A2 (en) 1993-08-19
WO1993016180A3 true WO1993016180A3 (en) 1993-09-30

Family

ID=11400692

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1993/000382 Ceased WO1993016180A2 (en) 1992-02-17 1993-02-17 Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95)

Country Status (5)

Country Link
CN (1) CN1076489A (en)
AU (1) AU3497893A (en)
IT (1) IT1254309B (en)
WO (1) WO1993016180A2 (en)
ZA (1) ZA931101B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175922A1 (en) * 1993-11-05 1995-05-11 Stefano Iacobelli Methods relating to ir-95
EP1248841B1 (en) * 2000-01-10 2008-07-23 Novartis Vaccines and Diagnostics, Inc. Genes differentially expressed in breast cancer
US7081517B2 (en) 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
AU3483001A (en) * 2000-02-04 2001-08-14 Corixa Corp Compositions and methods for the therapy and diagnosis of ovarian cancer
ITRM20090081A1 (en) 2009-02-25 2010-08-26 Stefano Iacobelli USE OF 90K PROTEIN INHIBITORS FOR THE PREPARATION OF A MEDICATION FOR THE CURE OR PREVENTION OF TUMORS.
CN101962405A (en) * 2010-09-30 2011-02-02 南开大学 Humanized breast cancer antigen and antibody thereof
CN110455848B (en) * 2018-05-08 2024-02-23 国家纳米科学中心 Iron ion longitudinal relaxation time sensor based on complexing reaction amplified signal, construction method and application thereof
EP3880706A1 (en) 2018-11-12 2021-09-22 MediaPharma S.r.l. Bispecific antibodies directed against human 90k and either endosialin or her3

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002735A1 (en) * 1984-11-02 1986-05-09 Oncogen Monoclonal antibodies and antigens for human non-small cell lung carcinomas
EP0453419A2 (en) * 1990-04-23 1991-10-23 Consiglio Nazionale Delle Ricerche Use of the SP-2 monoclonal antibody for diagnostics and for monitoring of the HIV infection progress

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002735A1 (en) * 1984-11-02 1986-05-09 Oncogen Monoclonal antibodies and antigens for human non-small cell lung carcinomas
EP0453419A2 (en) * 1990-04-23 1991-10-23 Consiglio Nazionale Delle Ricerche Use of the SP-2 monoclonal antibody for diagnostics and for monitoring of the HIV infection progress

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BREAST CANCER RESEARCH AND TREATMENT vol. 11, no. 1, 1988, BOSTON, US pages 19 - 30 Iacobelli, S. et al.; 'Measurement of a monoclonal antibody defined antigen 90K in sera of patients with ovarian cancer.' cited in the application *

Also Published As

Publication number Publication date
ITRM920100A0 (en) 1992-02-17
ZA931101B (en) 1994-08-17
ITRM920100A1 (en) 1993-08-17
AU3497893A (en) 1993-09-03
IT1254309B (en) 1995-09-14
WO1993016180A2 (en) 1993-08-19
CN1076489A (en) 1993-09-22

Similar Documents

Publication Publication Date Title
SG108208A1 (en) Connective tissue growth factor
AU1367095A (en) Effector proteins of rapamycin
WO2000073801A3 (en) Breast, gastric and prostate cancer associated antigens and uses therefor
CA2229028A1 (en) Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides
AU8131294A (en) Human kunitz-type protease inhibitors
CA2222747A1 (en) Dna sequence and encoded mammary-specific breast cancer protein
WO2000031235A3 (en) Nucleotide and protein sequences of nogo genes and methods based thereon
WO2000055180A3 (en) Human lung cancer associated gene sequences and polypeptides
KR950032279A (en) Peptides Related to Programmed Cell Death in the Human Body and DNA Encoding them
WO2000003685A3 (en) Nitrilase homologs
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
AU2633497A (en) Peptides having antiproliferative properties
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
AU9110798A (en) Hypoxia-regulated genes
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
WO1993016180A3 (en) Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95)
Gigli A single chain precursor of C4 in human serum
WO2000073509A3 (en) Molecules for diagnostics and therapeutics
Gill et al. A comparative structural analysis of the flagellin monomers of Caulobacter crescentus indicates that these proteins are encoded by two genes
WO1998002456A3 (en) Human c-type lectin
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
AU5076393A (en) Proteins which regulate the expression of vertebrate MHC class II genes, DNA sequences encoding them and pharmaceutical compositions
Bay et al. Unusual lactam formation occurring in the synthesis of a biotinylated T-antigen—serine derivative
CA2167630A1 (en) cDNA of DOCK180 Gene and DOCK180 Protein

Legal Events

Date Code Title Description
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT.BUL.20/93 UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

EX32 Extension under rule 32 effected after completion of technical preparation for international publication

Free format text: KZ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: PL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA